Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Melodiol Global Health Limited (ME1)
  6. Company Announcements

Melodiol Global Health Limited (ASX: ME1) - Announcements

Current share price for ME1 : $0.002 0.001 (33.33%)

ASX company news and announcements for Melodiol Global Health Limited (ME1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Melodiol Global Health Limited (ME1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Melodiol Global Health Limited (ME1), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Melodiol Global Health Limited (ME1)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$1 Trading Update 9 May 2024 8:24AM $0.003 $0.002 $0.003 fallen by 20%
$1 Secondary Trading Notice 3 May 2024 1:44PM $0.002 $0.002 $0.003 fallen by 0%
$1 Application for quotation of securities - ME1 3 May 2024 1:41PM $0.002 $0.002 $0.003 fallen by 0%
$1 Proposed issue of securities - ME1 2 May 2024 5:14PM $0.004 $0.002 $0.003 fallen by 50%
$1 Consolidation/Split - ME1 2 May 2024 5:14PM $0.004 $0.002 $0.003 fallen by 50%
$1 Notice of Annual General Meeting/Proxy Form 2 May 2024 5:13PM $0.004 $0.002 $0.003 fallen by 50%
$1 Final Director's Interest Notice 30 Apr 2024 4:42PM $0.004 $0.002 $0.003 fallen by 50%
$1 Proposed issue of securities - ME1 30 Apr 2024 4:41PM $0.004 $0.002 $0.003 fallen by 50%
$1 Appointment of Tim Tian as Group CFO 30 Apr 2024 4:40PM $0.004 $0.002 $0.003 fallen by 50%
$1 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 4:35PM $0.004 $0.002 $0.003 fallen by 50%
$1 Board Change 30 Apr 2024 10:55AM $0.003 $0.002 $0.003 fallen by 33.33%
$1 Update - Proposed issue of securities - ME1 22 Apr 2024 7:10PM $0.005 $0.002 $0.003 fallen by 60%
$1 Secondary Trading Notice 22 Apr 2024 6:36PM $0.005 $0.002 $0.003 fallen by 60%
$1 Application for quotation of securities - ME1 22 Apr 2024 6:31PM $0.005 $0.002 $0.003 fallen by 60%
$1 Proposed issue of securities - ME1 19 Apr 2024 5:51PM $0.005 $0.002 $0.003 fallen by 55.56%
$1 Corporate Update 19 Apr 2024 5:51PM $0.005 $0.002 $0.003 fallen by 55.56%
$1 Response to ASX Aware Letter 19 Apr 2024 4:15PM $0.005 $0.002 $0.003 fallen by 55.56%
$1 ME1 Q1 FY24 Revenue 16 Apr 2024 8:24AM $0.005 $0.002 $0.003 fallen by 60%
$1 Proposed issue of securities - ME1 9 Apr 2024 8:36AM $0.008 $0.002 $0.003 fallen by 75%
$1 Application for quotation of securities - ME1 9 Apr 2024 8:24AM $0.008 $0.002 $0.003 fallen by 75%
$1 Health House Australia and Corporate Update 9 Apr 2024 8:24AM $0.008 $0.002 $0.003 fallen by 75%
$1 Extension of Cleansing Offer Closing Date 8 Apr 2024 9:49AM $0.008 $0.002 $0.003 fallen by 75%
$1 Proposed issue of securities - ME1 2 Apr 2024 3:56PM $0.007 $0.002 $0.003 fallen by 71.43%
$1 Application for quotation of securities - ME1 2 Apr 2024 3:53PM $0.007 $0.002 $0.003 fallen by 71.43%
$1 Mernova Trading Update 2 Apr 2024 8:30AM $0.005 $0.002 $0.003 fallen by 60%

1 - 25 of 207 results

Page 1 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.